Endo Int'l (ENDP) Tops Q1 EPS by 4c, Guides FY Well Below Consensus

Endo Int'l (NASDAQ: ENDP) reported Q1 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $963.5 million versus the consensus estimate of $955.91 million.

GUIDANCE:

Endo Int'l sees FY2016 EPS of $4.50-$4.80, versus the consensus of $5.69. Endo Int'l sees FY2016 revenue of $3.87-4.03 million, versus the consensus of $4.29 million.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

You May Also Be Interested In

• Pacific Bio (PACB) says prelim. revenue for Q1 was below expectations due to customers delaying instrument purchases
• Ericsson shares rise as Q1 report reveals strong earnings, gross margin beat
• Bank of New York (BK) Tops Q1 EPS by 6c, Tops on Revenue